Feasibility of Urethra‐Sparing Ultra‐Hypofractionated Three‐Dose‐Level Radiotherapy for Prostate Cancer with a Dominant Intraprostatic Lesion Abutting the High‐Dose Avoidance Zone
Precision Radiation Oncology · 24.10.2026
DOI: 10.1002/pro6.70104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Precision Radiation Oncology, online erschienen am 24.10.2026. Verfasst von Annalisa Muscato und 4 weiteren Autor:innen. Beteiligte Einrichtung: Fondazione Istituto Oncologico del Mediterraneo Viagrande Italy. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This planning study evaluated ultra‐hypofractionated three‐dose‐level radiotherapy for prostate cancer with a dominant intraprostatic lesion (DIL) abutting the urethral high‐dose avoidance zone (HDAZ). Ten patients (30 volumetric modulated arc therapy [VMAT] plans) were re‐planned with 25 Gy to the pelvis, 35 Gy to the prostate, and 50 Gy to the DIL in five fractions. All plans achieved coverage while keeping urethral doses below the 90 GyEQD2 threshold and meeting organ‐at‐risk constraints, irrespective of DIL size or HDAZ contact. The findings demonstrate the feasibility of urethra‐sparing with effective DIL dose escalation, even in peri‐HDAZ locations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fondazione Istituto Oncologico del Mediterraneo Viagrande Italy.
- Department of Radiation Oncology REM Radioterapia srl Viagrande Italy.
- Department of Medicine and Surgery University Kore of Enna Enna Italy.
ORCID-Profile: Gianluca Ferini
Zitieren
APA
Muscato, A., La Fauci, D., Viola, A., Zagardo, V., & Ferini, G. (2026). Feasibility of Urethra‐Sparing Ultra‐Hypofractionated Three‐Dose‐Level Radiotherapy for Prostate Cancer with a Dominant Intraprostatic Lesion Abutting the High‐Dose Avoidance Zone. Precision Radiation Oncology. https://doi.org/10.1002/pro6.70104
Vancouver
Muscato A, La Fauci D, Viola A, Zagardo V, Ferini G. Feasibility of Urethra‐Sparing Ultra‐Hypofractionated Three‐Dose‐Level Radiotherapy for Prostate Cancer with a Dominant Intraprostatic Lesion Abutting the High‐Dose Avoidance Zone. Precision Radiation Oncology. 2026. doi:10.1002/pro6.70104
BibTeX
@article{Muscato2026,
author = {Muscato, Annalisa and La Fauci, Denis and Viola, Anna and Zagardo, Valentina and Ferini, Gianluca},
title = {Feasibility of Urethra‐Sparing Ultra‐Hypofractionated Three‐Dose‐Level Radiotherapy for Prostate Cancer with a Dominant Intraprostatic Lesion Abutting the High‐Dose Avoidance Zone},
journal = {Precision Radiation Oncology},
year = {2026},
doi = {10.1002/pro6.70104}
}
EUVIMED